Virtual Reality Intervention to Reduce Pain in Women Undergoing Elective Oocyte Cryopreservation (NCT07484815) | Clinical Trial Compass
RecruitingNot Applicable
Virtual Reality Intervention to Reduce Pain in Women Undergoing Elective Oocyte Cryopreservation
Israel100 participantsStarted 2024-11-05
Plain-language summary
This randomized controlled study evaluates whether exposure to relaxing virtual reality (VR) scenery prior to oocyte retrieval can reduce pain in women undergoing elective oocyte cryopreservation.
Many women experience discomfort before and after oocyte retrieval. Virtual reality has been shown to reduce pain in various medical settings by providing distraction and relaxation.
In this study, participants are randomly assigned to receive either routine care alone or routine care combined with a VR-based relaxation intervention while waiting for the procedure.
Pain is assessed using validated questionnaires and standardized scales before and after oocyte retrieval.
The results of this study may help determine whether VR can serve as a simple, safe, and non-pharmacological method to improve patient comfort during elective egg freezing.
Who can participate
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women undergoing elective oocyte retrieval for fertility preservation.
* Age 18-45 years.
* Ability to provide informed consent.
Exclusion Criteria:
* Use of pain relief, anti-anxiety, or antidepressant medications prior to the intervention.
* Any condition for which VR use is not recommended, including:
* History of seizures
* Sensitivity to flashing light or motion
* Migraine headaches
* Predisposition to nausea or dizziness (e.g., vertigo)
* Any injury to the eyes, face, or neck limiting use of the VR device, including blindness.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Post-procedure pain intensity
Timeframe: Immediately post-procedure in the recovery room (within 1 hour after oocyte retrieval)